Meeting
2018 ASCO Quality Care Symposium
Optimizing the use of trimethoprim-sulfamethoxazole for prevention of PCP and opportunistic infections in allogeneic hematopoietic cell transplant recipients.
Authors
Emily Baneman
Icahn School of Medicine at Mount Sinai, Department of Medicine, Division of Infectious Diseases, New York, NY
Emily Baneman, Nina Kim, Meenakshi Rana, Anne Sigrid Renteria, Amir S. Steinberg, Rita M. Jakubowski, Kendra Yum, Patricia Saunders, Samantha Jacobs
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Big Data Studies; Projects Relating to Equity, Value, and Policy
Track
Projects Relating to Equity, Value and Policy,Big Data Studies
Sub Track
Team-based Approaches to Optimizing Care Delivery
Citation
J Clin Oncol 36, 2018 (suppl 30; abstr 138)
DOI
10.1200/JCO.2018.36.30_suppl.138
Abstract #
138
Poster Bd #
N8
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Quality Care Symposium
Developing a standardized approach to prevention and outpatient management of febrile neutropenia.
First Author: Andrea Crespo
Poster
2024 ASCO Annual Meeting
Biomarkers in a phase 1b study of investigational microbiome therapeutic SER-155 in adults undergoing allogeneic hematopoietic cell transplantation (allo-HCT).
First Author: Doris M. Ponce
Poster
2023 ASCO Annual Meeting
A phase 1b study to evaluate the efficacy, safety, and pharmacokinetics of an investigational microbiome therapeutic, SER-155, in adults undergoing hematopoietic stem cell transplantation.
First Author: Doris M. Ponce
Poster
2023 ASCO Annual Meeting
Myeloablative fractionated busulfan-based conditioning regimen in patients with AML and MDS: Results of a randomized clinical trial comparing 2 fractionation schedules.
First Author: Uday R. Popat